Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.383418 
Contract referenceInst. Nac. de Cancer-2019-00940 
Contract description:MENTOS ONCOLÓGICOS 
Goods 
Contract Start:
17/10/2019 11:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
31/10/2019 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateCompleted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2019-0108 
MEDICAMENTOS ONCOLOGICOS 
MEDICAMENTOS ONCOLOGICOS 
LOGISTICA 
DOCTORES MALLEN GUERRA_EXT_CP001 
GoodsDominicana 
18,434,358.88 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
26/08/2019 17:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
25/11/2019 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments

REQ NO. AM-0144 SOLICITADO POR LOGÍSTICA

 
 
 1 
DO1.PCCNTR.748502 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
11,378,144.160.000.000.0019,389,906.0018,434,358.88
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
12352203 - Anticuerpos
2.3.7.2.99BEVACIZUMAB 100 MG INY65UD23,98624,800806,000.000.000.000.001,559,090.001,612,000.00
    
1
12352203 - Anticuerpos
2.3.7.2.99BEVACIZUMAB 400 MG INY48UD95,94697,827.012,372,562.430.000.000.004,605,408.004,695,696.48
    
51101835 - Acetato de cas(...)
2.3.4.1.01CETUXIMAB 5 MG170UD25,40025,4004,318,000.000.000.000.004,318,000.004,318,000.00
    
51101835 - Acetato de cas(...)
2.3.4.1.01ERLOTINIB 150 MG COMP120UD4,440.14,527.17271,630.200.000.000.00532,812.00543,260.40
    
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 1400 MG 11.7ML INY20UD109,61778,000780,000.000.000.000.002,192,340.001,560,000.00
    
51111716 - Rituximab
2.3.4.1.01RITUXIMAB 500 MG INY22UD92,37467,000737,000.000.000.000.002,032,228.001,474,000.00
    
51111717 - Trastuzumab
2.3.4.1.01TRASTUZUMAB 600 MG/5ML VIAL46UD90,21891,9872,092,951.530.000.000.004,150,028.004,231,402.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
Own resources
47,333,803.84 DOP
 DOP
AccountValueAnnual Availability
2.3.7.2.9920,525,050.00  DOP----View
2.3.4.1.0126,808,753.84  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
No items found...
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
201601147,333,803.84  DOP